NCT04048044

Brief Summary

Lying for 30 to 60 minutes daily in a field of 75 decibels of electromagnetic energy at 54 to 78 GHz will allow telomeres of white blood cells to regenerate

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jan 2009

Longer than P75 for phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

May 10, 2012

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
4.7 years until next milestone

First Posted

Study publicly available on registry

August 7, 2019

Completed
Last Updated

August 7, 2019

Status Verified

May 1, 2012

Enrollment Period

5.9 years

First QC Date

May 10, 2012

Last Update Submit

August 6, 2019

Conditions

Telomeres

Outcome Measures

Primary Outcomes (1)

  • Length of telomeres after 5 years compared with baseline

    5 years

Secondary Outcomes (1)

  • Total Symptom Index

    5 years

Study Arms (1)

Telomere length, GigaHz exposure

ACTIVE COMPARATOR

Measurement of white blood cell telomeres before and yearly for 5 years

Device: Exposure to GHz electromagnetic energy (RejuvaMatrix)

Interventions

Exposure to GHz electromagnetic energy (RejuvaMatrix)DEVICE

75 decibels of 54 to 78 GHz daily for 60 minutes

Telomere length, GigaHz exposure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Implanted electronic device
  • Major, debilitating disease
  • Person living with an individual who has an implanted device
  • Person who is or could become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Ph.D.

Study Record Dates

First Submitted

May 10, 2012

First Posted

August 7, 2019

Study Start

January 1, 2009

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

August 7, 2019

Record last verified: 2012-05